Risk of poststroke epilepsy low among young adults, reveals JAMA study
A new study published in the Journal of American Medical Association showed that young individuals had a comparatively low risk of poststroke epilepsy (PSE), and the parameters for the current risk scores can be applied to identify young patients at high risk.
Poststroke epilepsy patients frequently require long-term antiepileptic medication, which might have negative side effects, including depression, lethargy, lightheadedness, and behavioral abnormalities. Esmée Verburgt and her team therefore carried out this study to confirm existing PSE risk scores among a cohort of young individuals and to look into the risk of and risk factors for PSE at an early age.
Data from the ODYSSEY (Observational Dutch Young Symptomatic Stroke Study), a prospective cohort study that was carried out across 17 Dutch hospitals from May 27, 2013, to March 3, 2021, with follow-up until February 28, 2024, were used in this investigation. The primary exposure was the first ischemic stroke, or ICH, to be confirmed by neuroimaging.
Nearly, 1388 consecutive patients, between ages 18 to 49, who had no history of epilepsy and had an ischemic stroke or intracerebral hemorrhage (ICH) confirmed by neuroimaging were included in the study and 57 (4.1%) of them experienced PSE.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.